Page 9 - IJB-8-1

Section Headings institution on your behalf over the 36 months before submission of
the relevant work. Authors who have nothing to declare are
Please number the section headings (e.g. 1, 2, 3, 4, etc.) in encouraged to add "No conflict of interest was reported by all
boldface. Likewise, use boldface to identify subheadings too but authors" in this section.
please distinguish it from major headings using numbers
(e.g. 1.1, 1.2, 2.1, 2.2, etc.) Further subsections of subheadings During submission, the Conflict of Interest statement should be
should be differentiated by boldface and italics font with the included in both the cover letter and manuscript (beneath the
numbers (1), (2), (3), etc. Acknowledgments section).
Authors will be requested to complete ICMJE form for
Disclosure of Potential Conflict of
Introduction Interest (http://www.icmje.org/disclosure-of-interest/) when they
are invited to submit a revision. Failure to do return a completed
The introduction should provide a background that gives a broad form will result in a delay to editorial and peer review progress. If
readership an overall outlook of the field and the research necessary, the initial disclosure statement provided by the authors
performed. It tackles a problem and states its important regarding will be subject to edits for grammar corrections by the editors.
with the significance of the study. Introduction can conclude with a Failure to comply with the conflict of interest disclosure statement
brief statement of the aim of the work and a comment about requirement may result in rejection of the submissions.
whether that aim was achieved.

Funding
Materials and Methods
Authors should declare all financial and non-financial support that
This section provides the general experimental design and have the potential to be deemed as a source of competing interest
methodologies used. The aim is to provide enough detail to for in relations to their submitted manuscript in this section. Financial
other investigators to fully replicate the results. It is also required supports are generally in the form of grants, royalties, consulting
to facilitate better understanding of the results obtained. Protocols fees and others. Examples of non-financial support could include
and procedures for new methods must be included in detail for the the following: externally-supplied equipment/biological sources,
reproducibility of the experiments. Informed consent should be writing assistance, administrative support, contributions from non-
obtained from patients or parents before the experiments start and authors, etc.
should be mentioned in this section.

Appendix
Ethics
This section is optional and is for all materials (e.g. advanced
Ethics information include IACUC permit numbers and/or IRB technical details) that has been excluded from the main text but
name, if applicable. This information should be included in a remain essential to the readers in understanding the manuscripts.
subheading labelled "Ethics Statement" in the "Methods" section This section is not for supplementary figures. Authors are advised
of the manuscript file, in as much detail as possible.
to refer to the section on Supplementary Figures for such
submissions.

Results
This section can be divided into subheadings and focuses on the Text
results of the experiments performed. The text of the manuscript should be in Microsoft Word or Latex.
The length of the manuscript cannot be more than 50,000

characters (inclusive of spaces), or approximately 7,000 words.
Discussion

This section should provide the significance of the results and
identify the impact of the research in a broader context. It should Nomenclature for genes and proteins
not be redundant or similar to the content of the results section.
This journal aims to reach researchers all over the globe. Hence,
for reviewers’ and readers’ ease in comprehension, authors are

highly encouraged to use the appropriate gene and protein
Conclusion nomenclature. Authors may prefer to utilize resources such
as http://www.ncbi.nlm.nih.gov/gene.
Please use the conclusion section for interpretation only, and not
to summarize information already presented in the text or abstract.
Figures
Conflict of interest Authors should include all figures into the manuscript and submit
it as one file. Figures include photographs, scanned images,
All authors are required, at the time of submission, to declare all graphs, charts and schematic diagrams. Figures submitted should
activities that have the potential to be deemed as a source of avoid unnecessary decorative effects (e.g. 3D graphs), as well as
competing (commercial) interest in relation to their submitted should be minimally processed (e.g. changes in brightness and
manuscript, as consistent with the recommendations from the contrast applied uniformly for the entire figure). It should also be
International Committee of Medical Editors (ICMJE) set against a white background. Please remember to label all
(http://www.icmje.org/recommendations/). Examples of such figures (e.g. axis, etc.) and add captions below the figure, as
activities could include personal or work-related relationships, required. These captions should be numbered (e.g. Figure
events, etc. The disclosure should also include all sources of 1, Figure 2, etc.) in boldface. All figures must have a brief title
revenue paid (or promised to be paid) directly to authors or their (also known as caption) that describes the entire figure without
vii